PET/MRI in Endometrial Cancer

NCT05390021 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to enroll patients to study

Conditions

Cytoreductive Surgery
Grade 3 Endometrial Endometrioid Adenocarcinoma
High Grade Serous Carcinoma
Endometrial Undifferentiated Carcinoma
Endometrial Mixed Cell Adenocarcinoma

Interventions

COMBINATION_PRODUCT: PET/MRI with radiotracer ([18F]- fluorodeoxyglucose) and a gadolinium-based contrast agent

Sponsor

Massachusetts General Hospital